Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$605M |
| 2 |
American Tower
AMT
|
+$352M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$347M |
| 4 |
TJX Companies
TJX
|
+$309M |
| 5 |
ExxonMobil
XOM
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$924M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$617M |
| 3 |
United Parcel Service
UPS
|
+$546M |
| 4 |
Qualcomm
QCOM
|
+$540M |
| 5 |
Eaton
ETN
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.22% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.58% |
| 4 | Industrials | 8.26% |
| 5 | Consumer Discretionary | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Nuveen Real Asset Income & Growth Fund
JRI
$350M
| $796K | ﹤0.01% |
65,417
-657
| -1% | -$7.61K |
|
3177
Compass
COMP
$9.66B
| $796K | ﹤0.01% |
221,124
+8,400
| +4% | +$30.8K |
|
3178
Fate Therapeutics
FATE
$322M
| $795K | ﹤0.01% |
242,432
-41,958
| -15% | -$184K |
|
3179
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$602M
| $795K | ﹤0.01% |
73,589
-4,755
| -6% | -$51.4K |
|
3180
Nuveen Real Estate Income Fund
JRS
$244M
| $794K | ﹤0.01% |
98,668
-3,928
| -4% | -$29.2K |
|
3181
Anika Therapeutics
ANIK
$288M
| $793K | ﹤0.01% |
31,321
-8,203
| -21% | -$213K |
|
3182
Frontline
FRO
$8.73B
| $791K | ﹤0.01% |
30,847
+295
| +1% | +$7.51K |
|
|
JPI
3183
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
| $791K | ﹤0.01% |
40,305
+4,158
| +12% | +$79.6K |
|
3184
Allogene Therapeutics
ALLO
$732M
| $788K | ﹤0.01% |
338,045
+149,005
| +79% | +$440K |
|
3185
BlackRock Health Sciences Trust II
BMEZ
$1.01B
| $787K | ﹤0.01% |
51,242
-10,808
| -17% | -$164K |
|
3186
iShares Global REIT ETF
REET
$5.04B
| $786K | ﹤0.01% |
33,818
-113,026
| -77% | -$2.58M |
|
3187
Revolve Group
RVLV
$1.7B
| $785K | ﹤0.01% |
49,359
-5,384
| -10% | -$103K |
|
3188
Howard Hughes
HHH
$3.92B
| $784K | ﹤0.01% |
12,692
-179
| -1% | -$11.2K |
|
3189
FlexShares International Quality Dividend Index Fund
IQDF
$1.18B
| $784K | ﹤0.01% |
31,509
-1,665
| -5% | -$41.1K |
|
3190
Universal Technical Institute
UTI
$1.42B
| $783K | ﹤0.01% |
49,756
-104,568
| -68% | -$1.57M |
|
3191
8x8 Inc
EGHT
$295M
| $782K | ﹤0.01% |
352,354
-64,959
| -16% | -$158K |
|
3192
Byline Bancorp
BY
$1.77B
| $780K | ﹤0.01% |
32,874
| – | – |
|
|
FLIC
3193
DELISTED
First of Long Island Corp
FLIC
| $780K | ﹤0.01% |
77,855
+14,830
| +24% | +$150K |
|
3194
BlackRock MuniAssets Fund
MUA
$521M
| $777K | ﹤0.01% |
67,003
-8,942
| -12% | -$99.8K |
|
3195
iShares USD Green Bond ETF
BGRN
$501M
| $776K | ﹤0.01% |
16,666
-57
| -0.3% | -$2.64K |
|
3196
Constellium
CSTM
$4.02B
| $776K | ﹤0.01% |
41,168
-880,910
| -96% | -$18.3M |
|
3197
iShares MSCI Netherlands ETF
EWN
$723M
| $770K | ﹤0.01% |
+15,335
| New | +$768K |
|
|
PFL
3198
PIMCO Income Strategy Fund
PFL
$389M
| $770K | ﹤0.01% |
94,495
+495
| +0.5% | +$4.11K |
|
3199
Nuveen Churchill Direct Lending
NCDL
$614M
| $769K | ﹤0.01% |
+44,192
| New | +$778K |
|
|
BKN
3200
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
| $767K | ﹤0.01% |
64,205
-205
| -0.3% | -$2.46K |
|
Similar funds
Ameriprise's Q2 2024 Portfolio in Review
As of Q2 2024, Ameriprise held 3,986 positions worth $370B, up 1.7% from $363B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Ameriprise's Q2 2024 filing shows 147 new, 1,504 increased, 2,054 reduced and 132 closed positions. Its largest new stake was GE Vernova: 483,715 shares worth $83M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $924M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2024 buy was GE Vernova: 483,715 shares worth $83M.
- Ameriprise added most to Apple in Q2 2024, an estimated $605M increase.
- Ameriprise's biggest Q2 2024 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $924M.
- Ameriprise fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $313M.
- Ameriprise's ten largest holdings make up 20% of its $370B portfolio in Q2 2024.
- Ameriprise opened 147 new positions and closed 132 in Q2 2024.
- Ameriprise's portfolio value rose 1.7% quarter-over-quarter to $370B.
Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.